Somerset Drug Patent Portfolio
Somerset owns 1 orange book drug protected by 3 US patents Given below is the list of Somerset's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7150881 | Adhesive mixture for transdermal delivery of highly plasticizing drugs | 12 Jun, 2018 | Expired |
| US7070808 | Adhesive mixture for transdermal delivery of highly plasticizing drugs | 10 May, 2018 | Expired |
| US7638140 | Adhesive mixture for transdermal delivery of highly plasticizing drugs | 10 May, 2018 | Expired |
Latest Legal Activities on Somerset's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Somerset.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 31 Jan, 2022 | US7638140 |
|
Maintenance Fee Reminder Mailed
Critical
| 16 Aug, 2021 | US7638140 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Dec, 2017 | US7070808 |
|
Correspondence Address Change
Critical
| 25 Apr, 2014 | US7638140 |
|
Correspondence Address Change
Critical
| 25 Apr, 2014 | US7070808 |
| Post Issue Communication - Certificate of Correction | 01 Feb, 2011 | US7638140 |
|
Recordation of Patent Grant Mailed
Critical
| 29 Dec, 2009 | US7638140 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 29 Dec, 2009 | US7638140 |
|
Issue Notification Mailed
Critical
| 09 Dec, 2009 | US7638140 |
| Dispatch to FDC | 16 Nov, 2009 | US7638140 |
|
Application Is Considered Ready for Issue
Critical
| 16 Nov, 2009 | US7638140 |
|
Issue Fee Payment Received
Critical
| 11 Nov, 2009 | US7638140 |
|
Issue Fee Payment Verified
Critical
| 11 Nov, 2009 | US7638140 |
| Mail Examiner's Amendment | 22 Oct, 2009 | US7638140 |
|
Pubs Case Remand to TC
Critical
| 02 Sep, 2009 | US7638140 |
Somerset's Family Patents
Recently granted tentative Approvals to Somerset
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Somerset's portfolio.
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Rilpivirine | Rilpivirine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 20 Aug, 2025 |
| Eltrombopag Olamine | Eltrombopag Olamine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 05 Aug, 2025 |
Explore deeper patents analysis
Somerset Drug List
Given below is the complete list of Somerset's drugs and the patents protecting them.
1. Emsam
Emsam is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7150881 | Adhesive mixture for transdermal delivery of highly plasticizing drugs |
12 Jun, 2018
(7 years ago)
| Expired |
| US7070808 | Adhesive mixture for transdermal delivery of highly plasticizing drugs |
10 May, 2018
(7 years ago)
| Expired |
| US7638140 | Adhesive mixture for transdermal delivery of highly plasticizing drugs |
10 May, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Emsam's drug page